Ascensia Diabetes Care

Ascensia Diabetes Care is a global company dedicated to products and solutions for people with diabetes. Headquartered in Basel, Switzerland, it was established as a standalone company in 2016 following PHC Holdings’ acquisition of Bayer Diabetes Care. The company says its products are sold in more than 90 countries and that its diabetes-care heritage spans more than 80 years. Its best-known offering is the CONTOUR portfolio of blood glucose monitoring systems. Ascensia describes these products as combining accuracy, advanced technology and user-friendly functionality to help people incorporate glucose testing into everyday diabetes management. The company also offers digital diabetes-management solutions, including browser- and app-based tools for tracking, sharing and analyzing blood glucose readings. Its product range includes pen needles as well as monitoring systems and software. Ascensia’s stated focus is on developing practical tools that support self-management and respond to the needs of people with diabetes. Its digital offerings include the CONTOUR Diabetes app and GlucoContro.online, a diabetes data-management platform for healthcare professionals and people with diabetes. Product availability varies by country. Ascensia is a member of PHC Group, which the company says integrates environmental, social and governance principles into its business strategy.

Ascensia Diabetes Care presents its background as a legacy of diabetes-care research and product development extending more than 80 years. Its history page traces that legacy through earlier businesses and products. In 1941, the company’s predecessor history records the development of Clinitest, described as a convenient tablet test for measuring reducing substances in urine, such as glucose. In 1969, the former Ames division introduced the Ames Reflectance Meter, described by the company as the first portable blood glucose meter. The company’s milestones include the 1993 introduction of Glucometer Elite, which it describes as the first meter to use “sip-in” technology and the first low-volume blood glucose monitoring system, requiring a three-microliter sample. In 2003, it introduced blood glucose monitors with No Coding technology, including BREEZE and CONTOUR meters. In 2012, it introduced the first product in the CONTOUR NEXT meter portfolio, characterized as a next generation of highly accurate diabetes-management products. Ascensia Diabetes Care became a standalone company in 2016 following the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd., now referred to by the company as PHC Holdings. The company is headquartered in Basel, Switzerland, and describes itself as a member of PHC Group. Its subsequent product developments have included a smarter version of the CONTOUR Diabetes app, launched in 2018 with features to support self-management, and GlucoContro.online, launched in 2021 as a diabetes data-management platform for healthcare professionals and people with diabetes. The company’s history page also records the 2026 launch of CONTOUR COMFORT pen needles for daily insulin injections. Today, the company’s public-facing portfolio centers on CONTOUR blood glucose monitoring systems, digital diabetes-management solutions and pen needles. Ascensia says its products are sold in more than 90 countries, while noting that availability differs by market. Its stated mission is to improve the health and lives of people with diabetes through specialist expertise, innovation, and products designed for ease of use and everyday condition management.

• 2026

  CONTOUR COMFORT pen needles launched

• 2021

  GlucoContro.online launched

• 2018

  Updated CONTOUR Diabetes app launched

• 2016

  Ascensia Diabetes Care established as a standalone company

• 2012

  First CONTOUR NEXT meter introduced

• 2003

  No Coding monitors introduced

• 1993

  Glucometer Elite introduced

• 1969

  Ames Reflectance Meter introduced

• 1941

  Clinitest developed

A specialist diabetes-care company focused on accurate, user-friendly monitoring products and digital tools that support everyday diabetes management.

• CONTOUR blood glucose monitoring systems

  A portfolio of blood glucose monitoring systems described by Ascensia as accurate and easy to use.

• CONTOUR Diabetes app

  A digital diabetes-management solution; an updated version launched in 2018 with features supporting self-management.

• GlucoContro.online

  A diabetes data-management platform for healthcare professionals and people with diabetes, launched in 2021.

• CONTOUR COMFORT pen needles

  Pen needles launched in 2026 for daily insulin injections.

• Creation as a standalone company through acquisitionOther

• 2021-04-28

  Ascensia rolls out On@Pro educational platform[6]Ascensia推出On@Pro教育平台prnewswire.co.uk

  Reported: 2021-04-28

  Ascensia Diabetes Care announced that it had rolled out On@Pro, an online continuous-learning platform for healthcare professionals working with people with diabetes. The platform was developed in partnership with the TUMAINI Institute and was available in 13 countries at the time of the announcement.

1. 1Ascensia Diabetes Care | Innovative Diabetes Care Solutionsascensia.com
2. 2Our Historyascensia.com
3. 3Our Productsascensia.com
4. 4About Ascensia Diabetes Careascensia.com
5. 5Ascensia Diabetes Care (Switzerland)wikidata.org
6. 6Ascensia推出On@Pro教育平台prnewswire.co.uk